These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 38949964)
1. Discovery of BI-9508, a Brain-Penetrant GPR88-Receptor-Agonist Tool Compound for Fer M; Amalric C; Arban R; Baron L; Ben Hamida S; Breh-Schlanser P; Cui Y; Darcq E; Eickmeier C; Faye V; Franchet C; Frauli M; Halter C; Heyer M; Hoenke C; Hoerer S; Hucke OT; Joseph C; Kieffer BL; Lebrun L; Lotz N; Mayer S; Omrani A; Recolet M; Schaeffer L; Schann S; Schlecker A; Steinberg E; Viloria M; Würstle K; Young K; Zinser A; Montel F; Klepp J J Med Chem; 2024 Jul; 67(13):11296-11325. PubMed ID: 38949964 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship Studies. Rahman MT; Decker AM; Laudermilk L; Maitra R; Ma W; Ben Hamida S; Darcq E; Kieffer BL; Jin C J Med Chem; 2021 Aug; 64(16):12397-12413. PubMed ID: 34387471 [TBL] [Abstract][Full Text] [Related]
3. Discovery of a Potent, Selective, and Brain-Penetrant Small Molecule that Activates the Orphan Receptor GPR88 and Reduces Alcohol Intake. Jin C; Decker AM; Makhijani VH; Besheer J; Darcq E; Kieffer BL; Maitra R J Med Chem; 2018 Aug; 61(15):6748-6758. PubMed ID: 30011199 [TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Structure-Activity Relationship Studies of (4-Alkoxyphenyl)glycinamides and Bioisosteric 1,3,4-Oxadiazoles as GPR88 Agonists. Rahman MT; Decker AM; Langston TL; Mathews KM; Laudermilk L; Maitra R; Ma W; Darcq E; Kieffer BL; Jin C J Med Chem; 2020 Dec; 63(23):14989-15012. PubMed ID: 33205975 [TBL] [Abstract][Full Text] [Related]
5. Improvement of the Metabolic Stability of GPR88 Agonist RTI-13951-33: Design, Synthesis, and Biological Evaluation. Rahman MT; Decker AM; Ben Hamida S; Perrey DA; Chaminda Lakmal HH; Maitra R; Darcq E; Kieffer BL; Jin C J Med Chem; 2023 Feb; 66(4):2964-2978. PubMed ID: 36749855 [TBL] [Abstract][Full Text] [Related]
6. The GPR88 agonist RTI-13951-33 reduces alcohol drinking and seeking in mice. Ben Hamida S; Carter M; Darcq E; Sourty M; Rahman MT; Decker AM; Jin C; Kieffer BL Addict Biol; 2022 Nov; 27(6):e13227. PubMed ID: 36301207 [TBL] [Abstract][Full Text] [Related]
7. Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target. Ye N; Li B; Mao Q; Wold EA; Tian S; Allen JA; Zhou J ACS Chem Neurosci; 2019 Jan; 10(1):190-200. PubMed ID: 30540906 [TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Structure-Activity Relationship Studies of Novel GPR88 Agonists (4-Substituted-phenyl)acetamides Based on the Reversed Amide Scaffold. Rahman MT; Guan D; Chaminda Lakmal HH; Decker AM; Imler GH; Kerr AT; Harris DL; Jin C ACS Chem Neurosci; 2024 Jan; 15(1):169-192. PubMed ID: 38086012 [TBL] [Abstract][Full Text] [Related]
9. Discovery of Potent and Brain-Penetrant GPR52 Agonist that Suppresses Psychostimulant Behavior. Wang P; Felsing DE; Chen H; Stutz SJ; Murphy RE; Cunningham KA; Allen JA; Zhou J J Med Chem; 2020 Nov; 63(22):13951-13972. PubMed ID: 33198466 [TBL] [Abstract][Full Text] [Related]
10. The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disorders. Bi Y; Dzierba CD; Fink C; Garcia Y; Green M; Han J; Kwon S; Kumi G; Liang Z; Liu Y; Qiao Y; Zhang Y; Zipp G; Burford N; Ferrante M; Bertekap R; Lewis M; Cacace A; Westphal RS; Kimball D; Bronson JJ; Macor JE Bioorg Med Chem Lett; 2015 Apr; 25(7):1443-7. PubMed ID: 25754495 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of a high-throughput calcium mobilization assay for the orphan receptor GPR88. Decker AM; Gay EA; Mathews KM; Rosa TC; Langston TL; Maitra R; Jin C J Biomed Sci; 2017 Mar; 24(1):23. PubMed ID: 28347302 [TBL] [Abstract][Full Text] [Related]
12. Mapping GPR88-Venus illuminates a novel role for GPR88 in sensory processing. Ehrlich AT; Semache M; Bailly J; Wojcik S; Arefin TM; Colley C; Le Gouill C; Gross F; Lukasheva V; Hogue M; Darcq E; Harsan LA; Bouvier M; Kieffer BL Brain Struct Funct; 2018 Apr; 223(3):1275-1296. PubMed ID: 29110094 [TBL] [Abstract][Full Text] [Related]
13. GPR88 in A Meirsman AC; de Kerchove d'Exaerde A; Kieffer BL; Ouagazzal AM Eur J Neurosci; 2017 Aug; 46(4):2026-2034. PubMed ID: 28700108 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and evaluation of phenylglycinols and phenyl amines as agonists of GPR88. Dzierba CD; Bi Y; Dasgupta B; Hartz RA; Ahuja V; Cianchetta G; Kumi G; Dong L; Aleem S; Fink C; Garcia Y; Green M; Han J; Kwon S; Qiao Y; Wang J; Zhang Y; Liu Y; Zipp G; Liang Z; Burford N; Ferrante M; Bertekap R; Lewis M; Cacace A; Grace J; Wilson A; Nouraldeen A; Westphal R; Kimball D; Carson K; Bronson JJ; Macor JE Bioorg Med Chem Lett; 2015 Apr; 25(7):1448-52. PubMed ID: 25690789 [TBL] [Abstract][Full Text] [Related]
15. Activation and allosteric regulation of the orphan GPR88-Gi1 signaling complex. Chen G; Xu J; Inoue A; Schmidt MF; Bai C; Lu Q; Gmeiner P; Liu Z; Du Y Nat Commun; 2022 May; 13(1):2375. PubMed ID: 35501348 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and pharmacological evaluation of 4-hydroxyphenylglycine and 4-hydroxyphenylglycinol derivatives as GPR88 agonists. Jin C; Decker AM; Langston TL Bioorg Med Chem; 2017 Jan; 25(2):805-812. PubMed ID: 27956039 [TBL] [Abstract][Full Text] [Related]